368178.fig.005a
(a)
368178.fig.005b
(b)
368178.fig.005c
(c)
368178.fig.005d
(d)
Figure 5: Bladder cancer CD31 immunostaining for the groups under study: Control (a); BBN, in tumoral (b) and nontumoral hyperplastic (c) regions, and -3 + BBN (d). Original magnification 200x.